Traws Pharma Announces Key Approvals and Reverse Stock Split at 2024 Special Meeting
NEWTOWN, PA — Traws Pharma, Inc. (Nasdaq: TRAW) recently concluded its 2024 Special Meeting of Stockholders with significant decisions impacting the company’s capital structure. Shareholders approved all proposals outlined in the …
Traws Pharma Announces Key Approvals and Reverse Stock Split at 2024 Special Meeting Read More